Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Reinforced Stent Treats Venous Outflow Obstruction

By HospiMedica International staff writers
Posted on 17 Dec 2014
A new venous stent system conforms to the unique anatomy and pathophysiology of the venous system, including crush resistance, vessel coverage, and flexibility.

The Vici Venous Stent System is intended for use in veins of the lower extremities and pelvis, including the iliac and common femoral veins, and in patients who exhibit symptomatic venous outflow obstruction. More...
The system comprises two components: the stent implant itself and the disposable delivery system. The stent is a laser cut, self-expanding tube made of a nickel titanium alloy (nitinol) with closed-cell segments and proprietary bridges and braces, designed to provide strength and flexibility in the venous anatomy.

Since venous disease requires a high degree of crush resistance, the radial stiffness of the venous stent is maximized to resist compression and improve vessel patency. The delivery system is a coaxial, over-the-wire (OTW) design with an exterior shaft to protect and constrain the stent prior to deployment. It is compatible with a 9F sheath introducer, and can be delivered via either a jugular or femoral vein approach. The Vici Venous Stent System is a product of Veniti (St. Louis, MO, USA), and has received the European Community CE marking of approval.

“The Veniti Vici venous stent appears to have the radial strength and vein coverage to provide optimal results in patients with symptomatic outflow obstruction of the lower extremities,” said Stephen Black, MD, a consultant vascular surgeon at St. George’s Vascular Institute (London, United Kingdom), who implanted Veniti Vici stents in five patients with symptomatic venous outflow obstruction of the lower extremities. “Having a stent that was designed from its inception for use in veins makes this an important addition to my treatment options.”

Symptomatic venous outflow obstruction of the iliofemoral vein is a common complication of deep vein thrombosis (DVT) and May-Thurner syndrome (MTS), which is caused when the left iliac vein is compressed by the right iliac artery, which increases the risk of DVT in the left extremity. Until the advent of stents, patients did not have many options, and were treated with compression stockings, by elevating the leg, or with different pharmaceutical agents.

Related Links:

Veniti



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.